The Food and Drug Administration (FDA) approved bemotrizinol as a permitted active ingredient in sunscreens on June 9, 2026. This marks the first addition of a new sunscreen ingredient since the late 1990s. According to an FDA release, bemotrizinol offers protection against both ultraviolet A and B rays and has low levels of absorption through the skin.
✓ AI-Debiased Article
4
Wire-neutral
provisional
FDA approves bemotrizinol as new sunscreen ingredient
The FDA has approved bemotrizinol as a new active ingredient in sunscreens, the first such approval in over 20 years. The ingredient is noted for its effectiveness against UV rays and minimal skin absorption.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
FDA approves first new sunscreen ingredient in more than 20 years
Neutral Headline
FDA approves bemotrizinol as new sunscreen ingredient
